Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against ...
The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.